(Reuters) - The U.S. Food and Drug Administration on Tuesday rejected Prevention Bio Inc.'s approval of the experimental diabetes drug teplizumab, citing insufficient data,...
A recent market study highlights some of the key factors likely to influence the growth of the wearable fitness electronics and technology market over...